Avatrombopag d8

Product Name Avatrombopag d8
CAT No. CS-EO-02504
CAS No. 570406-98-3 (Unlabelled)
Category Stable Isotopes
Stock Enquire
Mol. Wt. 657.7 g/mol
Mol. For. C29H26D8Cl2N6O3S2
Hazardous This is not a Hazardous Compound
COA View Sample COA
MSDS View Sample MSDS
Controlled No
Shipping Free for purchase above 1000$
Delivery In stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries.
Return Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product).
Ordering Place your order online or by email sales@clearsynth.com

What is the usage and chemical information of Avatrombopag d8 ?


Avatrombopag d8 is a deuterated version of Avatrombopag, a small molecule agonist of the thrombopoietin receptor used for the treatment of thrombocytopenia in patients with chronic liver disease. Thrombocytopenia is a condition characterized by a low platelet count in the blood, which can lead to excessive bleeding or bruising. Avatrombopag d8 works by stimulating the production of platelets in the bone marrow, thereby increasing the platelet count in the blood. Chemically, Avatrombopag d8 is a deuterated derivative of Avatrombopag, which means that some of the hydrogen atoms in the molecule have been replaced with deuterium atoms. This modification results in a heavier molecule, which has several advantages over the non-deuterated version. For example, Avatrombopag d8 has a longer half-life in the body, which means that it can be administered less frequently. Additionally, deuterated molecules are often more stable than their non-deuterated counterparts, which can reduce the risk of side effects and improve the efficacy of the drug. Avatrombopag d8 is typically administered orally, in the form of a tablet. The recommended dose varies depending on the patient's weight and medical history, and should be determined by a qualified healthcare professional. Common side effects of Avatrombopag d8 include headache, nausea, and fatigue. In rare cases, the drug may cause more serious adverse reactions, such as liver toxicity or blood clots. Patients taking Avatrombopag d8 should be closely monitored by a healthcare professional to ensure that the drug is safe and effective for their specific condition.

This page contains information about Avatrombopag d8. You can buy Avatrombopag d8 from Clearsynth at best competitive price with assured price guarantee. Clearsynth offers best quality Avatrombopag d8